stoxline Quote Chart Rank Option Currency Glossary
  
Quest Diagnostics Incorporated (DGX)
137.455  0.435 (0.32%)    06-18 11:53
Open: 136.33
High: 137.75
Volume: 180,694
  
Pre. Close: 137.02
Low: 136.33
Market Cap: 15,270(M)
Technical analysis
2024-06-18 11:19:23 AM
Short term     
Mid term     
Targets 6-month :  165.93 1-year :  170.08
Resists First :  142.07 Second :  145.61
Pivot price 140.09
Supports First :  136.33 Second :  113.42
MAs MA(5) :  137.86 MA(20) :  140.34
MA(100) :  132.65 MA(250) :  132.95
MACD MACD :  -0.1 Signal :  0.7
%K %D K(14,3) :  9.4 D(3) :  13.1
RSI RSI(14): 41.9
52-week High :  145.61 Low :  119.58
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ DGX ] has closed above bottom band by 12.3%. Bollinger Bands are 10.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 138.65 - 139.98 139.98 - 140.78
Low: 133.71 - 135.49 135.49 - 136.56
Close: 135 - 137.87 137.87 - 139.6
Company Description

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Headline News

Tue, 18 Jun 2024
Spartan Planning & Wealth Management Takes Position in Quest Diagnostics Incorporated (NYSE:DGX) - Defense World

Tue, 18 Jun 2024
Wellington Management Group LLP Increases Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - Defense World

Mon, 17 Jun 2024
V Square Quantitative Management LLC Acquires 511 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - Defense World

Sun, 16 Jun 2024
DGX - Quest Diagnostics Incorporated Latest Stock News & Market Updates - StockTitan

Fri, 14 Jun 2024
Quest Diagnostics Inc. stock underperforms Friday when compared to competitors - MarketWatch

Thu, 13 Jun 2024
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out 111 (M)
Shares Float 110 (M)
Held by Insiders 0.4 (%)
Held by Institutions 93 (%)
Shares Short 2,700 (K)
Shares Short P.Month 3,020 (K)
Stock Financials
EPS 7.42
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 57.95
Profit Margin 9.1 %
Operating Margin 13.3 %
Return on Assets (ttm) 6.1 %
Return on Equity (ttm) 14.1 %
Qtrly Rev. Growth 1.5 %
Gross Profit (p.s.) 0
Sales Per Share 83.62
EBITDA (p.s.) 16.02
Qtrly Earnings Growth -3.5 %
Operating Cash Flow 1,330 (M)
Levered Free Cash Flow 784 (M)
Stock Valuations
PE Ratio 18.45
PEG Ratio 3.2
Price to Book value 2.36
Price to Sales 1.63
Price to Cash Flow 11.45
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android